- Filed Under
The FDA has approved yet another blood-clotting dressing, giving service members another option to treat high-pressure bleeding, one of the top three threats to troops serving in Iraq and Afghanistan.
WoundStat, produced by TraumaCure, joined the ranks of Celox, QuikClot and HemCon — the last of which is issued to troops in Iraq — as tools troops could use to treat wounds a tourniquet can't reach.
WoundStat was developed by Virginia Commonwealth University's Reanimation Engineering Shock Center, which also conducted a study showing the pre-mixed dressing compound can stop arterial hemorrhaging in three minutes, and keep it stopped for two hours. The new product will be available for use by the end of fall, according to a company statement.